The newly approved injectable, Yeztugo (lenacapavir), protects against HIV with just two subcutaneous injections every six ...

PEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...

Lenacapavir has been incredibly promising in trials and now the World Health Organisation have officially recommended the drug for HIV prevention. Smitha Mundasad explains the difference this ...

The Global Fund has announced that it signed an access agreement with Gilead Sciences to procure lenacapavir, a twice-a-year injection that has a 99 per cent success rate in preventing HIV ...

Results from the Phase III PURPOSE 1 (NCT04994509) and PURPOSE 2 (NCT04925752) trials highlight Yeztugo’s (lenacapavir) ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Explore breast implant surgery in India: trusted by international patients for natural outcomes and world-class standards.

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

THE PHILIPPINE National AIDS Council (PNAC) and AIDS Healthcare Foundation (AHF) Philippines on Thursday said the procurement of the vaccine lenacapavir is underway following the rapid spike of human ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...